A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to argenx
Related studies linked through entity extraction aliases.
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Status
- RECRUITING
- Phase
- N/A
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
- Status
- RECRUITING
- Phase
- N/A
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
- Status
- TERMINATED
- Phase
- PHASE2
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
- Status
- TERMINATED
- Phase
- PHASE3
A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single and Multiple Ascending Doses of ARGX-119 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3